Brief: GE, Global Good Licensing deal with Access Bio brings asymptomatic malaria rapid diagnostic tests to market

Access Bio

12/07/2017 16:00

July 12 (Reuters) - GE 
    * GE, global good licensing deal with Access Bio brings 
asymptomatic malaria rapid diagnostic tests to market 
    * Agreement includes technology to create malaria serology 
tests for plasmodium antibodies which can measure population's 
past exposure to disease 
    * Agreement covers diagnostic test that identifies key 
proteins present in malaria, as well as PLDH RDT to detect 
malarial parasites 
 
Source text for Eikon:  ID:nBw4bZryha  
Further company coverage:  950130.KQ  
 
 ((Bangalore.newsroom@thomsonreuters.com;))